Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Resmed Inc banner

Resmed Inc
ASX:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
ASX:RMD
Watchlist
Price: 34.17 AUD -4.63% Market Closed
Market Cap: AU$33.4B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

RMD Price Targets Summary
Resmed Inc

Wall Street analysts forecast RMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMD is 44.16 AUD with a low forecast of 33.8 AUD and a high forecast of 52.7 AUD.

RMD Lowest Forecast
Wall Street Target
33.8 AUD
-1% Downside
RMD Average Forecast
Wall Street Target
44.16 AUD
29% Upside
RMD Highest Forecast
Wall Street Target
52.7 AUD
54% Upside
Lowest
Price Target
33.8 AUD
1% Downside
Average
Price Target
44.16 AUD
29% Upside
Highest
Price Target
52.7 AUD
54% Upside
Resmed Inc Competitors:
Price Targets
CAR
Avis Budget Group Inc
24% Upside
9688
Zai Lab Ltd
92% Upside
CAR
Avis Budget Group Inc
24% Upside
9688
Zai Lab Ltd
92% Upside

Revenue
Forecast

11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Resmed Inc's revenue is 11%. The projected CAGR for the next 3 years is 8%.

What are analyst estimates?

Operating Income
Forecast

14% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
14% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Resmed Inc's operating income is 14%. The projected CAGR for the next 3 years is 12%.

What are analyst estimates?

Net Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for Resmed Inc's net income is 14%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

See Also

Summary
RMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RMD stock valuation using valuation multiples.
Wall Street Estimates
RMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RMD's stock price target?
Price Target
44.16 AUD

According to Wall Street analysts, the average 1-year price target for RMD is 44.16 AUD with a low forecast of 33.8 AUD and a high forecast of 52.7 AUD.

What is Resmed Inc's Revenue forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Resmed Inc's revenue is 11%. The projected CAGR for the next 3 years is 8%.

What is Resmed Inc's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Resmed Inc's operating income is 14%. The projected CAGR for the next 3 years is 12%.

What is Resmed Inc's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Resmed Inc's net income is 14%. The projected CAGR for the next 3 years is 11%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.